Skip to main content

Table 3 Relative importance of medication harms and benefits a - individual level

From: Understanding rational non-adherence to medications. A discrete choice experiment in a community sample in Australia

Comparison Number of respondents (%), (n = 161)
Harms (overall) > Benefits (overall)b 94 (58%)
Harms (immediate) > Harms (long-term)c 86 (53%)
Benefits (immediate) > Benefits (long-term)d 30 (19%)
  1. a Using individual parameter estimates, the relative importance of factors for medication harms and benefits was investigated using the coefficient range for each factor. The coefficient range is the difference between the smallest (negative) part worth utility and the largest part worth utility within factor levels.
  2. b This represents the number of respondents with the sum of the coefficient ranges for the factors “severity of current side effects” and “chance of future unwanted medication effects” greater than the sum of the coefficient ranges for the factors “frequency of symptoms while on the medication (current)” and “chance of early death from the illness while on the medication (future)”.
  3. c This represents the number of respondents with the coefficient range for the factor “severity of current side effects” greater than the coefficient range for the factor “chance of future unwanted medication effects”.
  4. d This represents the number of respondents with the coefficient range for the factor “symptom frequency while on medication (current)” greater than the coefficient range for the factor “chance of early death from the illness while on the medication (future)”.